Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of E0671 and Rabeprazole Sodium in Gastric Ulcer
NCT00125736Phase 4Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Aug 2005
- Primary completion
- Apr 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in gastric ulcer comparing E0671 combination group with Placebo combination group (2 arms). Primary endpoint: Ratio of S2-stage transition at 8 weeks. Started Aug 2005; status: completed.
02
Drugs
teprenone
03
Conditions
gastric ulcer
Beyond the preview
Go deeper on NCT00125736.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00125736.